Quick Answer
Progyny, Inc. reported Stockholders Equity of $516.04 million for the year ending 2025.
- Progyny, Inc. showed an increase of +22.3% in Stockholders Equity from 2024 to 2025.
- This data is from Progyny, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: -$92.80 million | Q3 2018: -$94.30 million | Q1 2019: -$92.08 million | Q2 2019: -$89.51 million | Q3 2019: -$91.25 million | Q1 2020: $119.49 million | Q2 2020: $118.71 million | Q3 2020: $125.89 million | Q1 2021: $184.62 million | Q2 2021: $204.54 million | Q3 2021: $224.11 million | Q1 2022: $279.62 million | Q2 2022: $311.02 million | Q3 2022: $346.86 million | Q1 2023: $424.40 million | Q2 2023: $469.50 million | Q3 2023: $515.39 million | Q1 2024: $571.60 million | Q2 2024: $456.19 million | Q3 2024: $434.88 million | Q1 2025: $467.16 million | Q2 2025: $515.02 million | Q3 2025: $560.00 million.
- Over the full 9 years of available data (2017 to 2025), Progyny, Inc.'s Stockholders Equity has grown by 628.6%.
- Historical annual values: Fiscal year 2025: $516.04 million | Fiscal year 2024: $422.06 million | Fiscal year 2023: $553.43 million | Fiscal year 2022: $376.97 million | Fiscal year 2021: $251.82 million | Fiscal year 2020: $166.95 million | Fiscal year 2019: $114.27 million | Fiscal year 2018: -$95.12 million | Fiscal year 2017: -$97.62 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: